DOI: http://dx.doi.org/10.18203/2319-2003.ijbcp20160653

Understanding the degree of awareness among medical professionals regarding the ethics of pharmaceutical marketing activities in context of revised medical council of India code of ethics

Renuka H. Munshi, Kanchan R. Singh, Astha D. Thakkar

Abstract


Background: Pharmaceutical marketing activities are regarded as ethically challenging by most medical professionals. This study was planned to understand the extent of the interaction of pharmaceutical companies with healthcare providers & to determine the level of awareness about the ‘Medical Council of India (MCI) Code of Ethics’.

Methods: A questionnaire based survey was conducted among 100 consultants and residents. The questionnaire mainly dealt with ethical issues about accepting free gifts, medicines and other sponsorships from pharmaceutical representatives, interactions and expectations from representatives of pharmaceutical companies by doctors and ascertaining among them the level of awareness about the MCI’s code of ethics.

Results: 59.4% residents and 58.8% consultants do not consider small gifts (stationery/books/drug samples) as ethically problematic. 88% residents and 85% consultants felt that offers should be limited. 72% of consultants were aware of the revised MCI code of ethics as compared to 28% of residents.

Conclusions: Most physicians do maintain a code of ethics with regards to accepting gifts and they felt that inexpensive gifts do not influence clinical judgment. Consultants were of the view that amended MCI code of ethics would not affect their clinical practice significantly.


Keywords


Codes of ethics, Medical workforce, Pharmaceutical marketing, Gifts

Full Text:

PDF

References


International code of medical ethics of the world medical association, 1949. Available at http://www.cirp.org/library/ethics/intlcode/; Accessed 1 February 2016.

Indian medical council (professional conduct, etiquette and ethics) regulations, 2002. Available at http://mohfw.nic.in/code.htm. Accessed on 1st February 2016.

Wall LL, Brown D. The high cost of free lunch. Obstetr Gynecol. 2007;110(1):169-73.

Persuading the prescribers: pharmaceutical industry. Marketing and its influence on physicians and patients. 2013. Available at http://www.pewtrusts.org/en/research-and-analysis/ fact-sheets/2013/11/11/persuading-the-prescribers-pharmaceutical-industry-marketing-and-its-influence -on-physicians-and-patients. Accessed on 1 February 2016.

Medical council of India code of ethics regulations, 2002. Amendment Notification New Delhi, 2009. Available at http://www.mciindia.org/ KNOW/ rules/ethics.htm. Accessed on 1 February 2016.

McGuaran A. Royal college issues new guidelines on gifts from drugs companies BMJ. 2002;325(7363):511.

Liu YM, Yang YH, Hsieh CR. Financial incentives and physicians’ prescription decisions on the choice between brand-name and generic drugs: evidence from Taiwan. J Health Econ. 2009;28:341-9.

Wazana A. Physicians and the pharmaceutical industry. Is a gift ever just a gift? JAMA. 2000;283:373-80.

McKinney WP, Schiedermayer DL, Lurie N, Simpson DE, Goodman JL, Rich EC. Attitudes of internal medicine faculty and residents toward professional interaction with pharmaceutical sales representatives. JAMA. 1990;264:1693-7.

Bowman MA, Pearle DL. Changes in drug prescribing patterns related to commercial company funding of continuing medical education. J Cont Educ Health Prof. 1988;8:13-20.

Orlowski JP, Wateska L. The effects of pharmaceutical firm enticements on physician prescribing patterns. Chest. 1992;102:270-3.

Bowman MA. The impact of drug company funding on the content of continuing medical education. Mobius. 1986;6:66-9.

Walker G. Code of practice for the pharmaceutical Industry. In: ABPI Data Sheet Compendium. Association of British Pharmaceutical Industry. London: Datapharm Publications; 1993:VI-XIII.

Editorial. Drug promotion: stealth, wealth and safety. Lancet. 1993;341:1507-8.

Zipkin DA, Steinman MA. Interactions between pharmaceutical representatives and doctors in training. J Gen Intern Med. 2005;20(8):777-86.

Campbell E, Gruen R, Mountford J, Miller L, Clearly P, Blumenthal D. A national survey of physician-industry relationships. N Engl J Med. 2007;356:1742-50.

Gibbons R, Landry F, Blouch D, Jones DL, Williams FK, Lucey CR et al. A comparison of physicians' and patients' attitudes toward pharmaceutical industry gifts. J Gen Intern Med. 1998;13:151-4.

Randall ML, Rosenbaum JR, Rohrbaugh RM, Rosenheck RA. Attitudes and behaviors of psychiatry residents toward pharmaceutical representatives before and after an educational intervention. J Med Ethics. 2006;32(10):559-63.

Gulhati CM. Marketing of medicines in India. BMJ. 2004; 328:778-9.

Ziegler MG, Lew P, Singer BC. The accuracy of drug information from pharmaceutical sales representatives. J American Med Assoc. 1995;273:1996-8.

Caudill T, Johnson M, Rich E, McKinney P. Physicians, pharmaceutical sales representatives, and the cost of prescribing. Arch Fam Med. 1996;5:201-6.

Bower A, Burkett G. Family physicians and generic drugs: a study of recognition, Information sources, prescribing attitudes, and practices. J Fam Pract 1987;24:612-6.

Bhatt AD. Drug promotion and doctor: a relationship under change? J Postgrad Med. 1993;39:120-3.

Bal A. Can the medical profession and the pharmaceutical industry work ethically for better health care? Indian J Med Ethics. 2004;1:17-8.

Roy N. Who rules the great Indian drug bazaar? Indian J Med Ethics. 2004;1:2-3.

Anand AC. The pharmaceutical industry: Our ′silent partner′ in the practice of medicine. Natl Med J India. 2000;13:319-21.

Kalantri SP. Drug industry and medical conferences. Indian J Anaesth. 2004;48:28-30.

Verma SK. Physician-pharmaceutical industry interaction: changing dimensions and ethics. Indian Pediatr. 2004;41:29-36.

Banks JW, Mainous AG. Attitudes of medical school faculty toward gifts from the pharmaceutical industry. Acad Med. 1992;67:610-2.

Lichstein PR, Turner RC, O’Brien K. Impact of pharmaceutical company representatives on internal medicine residency programs: a survey of residency program directors. Arch Intern Med. 1992;152:1009-13.

Brotzman GL, Mark DH. The effect on resident attitudes of regulatory policies regarding pharmaceutical representative activities. J Gen Intern Med. 1993;8:130-4.

Poirier TI, Giannetti V, Guidici RA. Pharmacists’ and physicians’ attitudes toward pharmaceutical marketing practices. Am J Hosp Pharm. 1994;51:378-81.

Steinman MA, Shlipak MG, McPhee SJ. Of principles and pens: attitudes and practices of medicine house staff toward pharmaceutical industry promotions. Am J Med. 2001;110:551-7.